Controlled clinical trials of human subjects using new drugs, devices, treatments or diagnoses or comparisons of authorized drugs, devices, treatments or diagnoses to assess safety, efficacy, benefits, costs, side effects and/or outcomes. These studies can be carried out as part of a protocol developed by the industry or a protocol developed by the examiner. In a letter dated 12 February 2019, addressed to the Chancellors and Vice-President of the NRA, Chief Financial Officer Nathan Brostrom confirmed that, according to the first escalation of the IDC rate (from 25% to 30% of MTDC), the agreements on the campus of all authorities of the California Bundesstaates, with the exception of the California Department of Food and Agriculture (CDFA), with an effective date on July 1, 2019 or later, require a 30% recovery of MTDC. This rate does not apply to federal funds that are transferred to the UC through a California public authority, as shown below. The following rates apply from 24.04.18 until the change. Premiums issued with the May 23, 2012 rates will apply the old rates until the end of the competition segment and the new rates should apply to all competitive extensions. (See prices and agreement of May 23, 2012.) For “training actions”, a reduced rate of 8% of MTDC is accepted, in accordance with the NIH`s research and development limitation for institutional training grants. This rate can be used for training grants that support the UC`s educational mission and does not apply in cases where a UC campus provides training to a state agency. Research and development costs are estimated at $25,000 for each competitive project period.

Direct costs of tuition and issuance fees (including university health insurance) for university students. Subcontracting rates for federal grants and contracts with launch dates prior to November 27, 2017 remain set for the duration of the main agreement (i.e. the Prime Award competition period) under the previous collective research and development agreement that expired. Circular OMB A-21 provides that indirect costs are allocated on the basis of a modified total direct cost (MTDC). In the case of sponsored agreements with government-negotiated tariffs, indirect costs are not estimated at direct expenditures identified as exclusions from MTDC. The cost of these services should be based on a currently effective patient care rate, negotiated by DHHS, or on an equivalent contract. UC`s individual campuses do not have the delegated authority to reduce or waive the campus-negotiated rate for a public authority passport. In addition, the reduction in campus`s ADF rate should not be “encouraged or coerced in any way by the federal allocation agency or the passport unit,” as stated in the CFO Council FAQ. If the above criteria are applied, all subcontracting costs are excluded and each year of the project requires a separate analysis. Formal approval of the use of an on- and off-campus rate for a proposed competition is required by the Industry Contracts Divison and this authorization must be obtained before a proposal can be submitted to a sponsor.

The R and R Off-campus D is used when the project is implemented throughout the project in institutions that are not in possession or leased. If leased land and rental fees are charged directly to the project, the outside of the campus rate must be used. Note: The off-campus rate is not applied when a senior auditor (PI) decides to carry out his or her project off-campus for convenience (i.e., when campuses or other academic institutions are available). Other Clinical Services (R): Single sale of a pre-developed clinical trial or clinical evaluation service (e.g.B. X-ray, irM) by a UC faculty member and associate staff. If the test is modified, improved or developed in any way to provide the service, then the agreement is classified as sponsored research.